This article is more than 5 years old. Information may no longer be current.
ASH awards ‘bridge grants’
Click Here to Manage Email Alerts
ASH announced the 11 recipients of its latest round of bridge grants. The 1-year, $150,000 awards are intended to provide interim support for hematology research proposals that, despite earning high scores, could not be funded by the NIH due to severe funding reductions.
The recipients are Jeffrey M. Lipton, MD, PhD, of The Feinstein Institute for Medical Research/Cohen Children’s Medical Center; Jing-fei Dong, MD, PhD, of Puget Sound Blood Center and Program; Marie-Dominique Filippi, PhD, of Cincinnati Children’s Research Foundation; Matthew A. Young, PhD, of University of Michigan; Neil A. Goldenberg, MD, PhD, of Johns Hopkins University; Renhao Li, PhD, of Emory University; Runqing Lu, PhD, of University of Nebraska Medical Center; Saghi Ghaffari, MD, PhD, of Icahn School of Medicine at Mount Sinai; Sridhar Rao, MD, PhD, of BloodCenter of Wisconsin; Todd E. Druley, MD, PhD, of Washington University in St. Louis; and Wendy Czen, DO, MPH, of Keck School Medicine of USC.
Sixty-two hematologists have received ASH bridge grants since the society committed $9 million to create the program in 2012.
David A. Williams
“After a decade of flat funding for NIH, sequestration-related cuts, and now a great deal of uncertainty for NIH amid ongoing congressional budget negotiations, the need for bridge funding programs like ASH’s has never been greater,” ASH President David A. Williams, MD, of Boston Children’s Hospital and Harvard Medical School, said in a press release. “By supporting this promising research, ASH is helping to sustain laboratories and retain hematologists in the field. We simply cannot afford to allow these detrimental spending cuts to halt the progress of talented and passionate investigators, especially when major breakthroughs are on the horizon.”